CD4 and infection: Subjects with well-controlled infection were more likely to have nadir CD4 count > 500 (13.4% vs. 7.0%, p-value < 0.0001), >80% of follow-up time on ART (48.2% vs. 12.1%, p-value < 0.0001) and received a statin (50.6% vs. 31.4%, p-value < 0.0001) by end of follow-up than those with poorly controlled HIV.